All News

A recent population-based analysis reveals lifestyle and health factors that appear to undermine male fertility.

The study shows a wide discrepancy between the least and most expensive ways to treat the common prostate condition.

A new testosterone nasal gel (Natesto) is safe and efficacious, according to phase III data presented at the Endocrine Society annual meeting in San Diego.

A handful of new studies reveal new information about risk factors for both low and high testosterone as well as the potential risks associated with each.

The AUA, Large Urology Group Practice Association (LUGPA), and American Association of Clinical Urologists (AACU) would like to see the U.S. Preventive Services Task Force (USPSTF) revamp the methods it uses to develop recommendations on prostate cancer screening and other preventive care, and the three associations are now backing legislation that would do just that.

The FDA acted on recommendations from one of its advisory committees by requiring manufacturers of testosterone therapies to make label changes that restrict the drugs’ usage.

New, large-scale studies on active surveillance, IMRT complications, and robotic versus open prostatectomy were among the highlights of this year’s Genitourinary Cancers Symposium.

The review “represents the best available evidence for the morbidity and cost profile” of robot-assisted versus open radical prostatectomy, says one of the study’s authors.

One minute of a physician’s time could help determine how likely a urologic patient is to experience complications after an operation, say researchers from Emory University School of Medicine, Atlanta.

Uroplasty, Inc. announced that Cigna has written a positive coverage policy for percutaneous tibial nerve stimulation delivered via Uroplasty's Urgent PC neuromodulation system for treatment of overactive bladder and associated symptoms of urinary urgency, urinary frequency, and urge incontinence.

This video demonstrates one of the most simple and reliable urethroplasty techniques: excision and primary anastomosis of the urethra.

This video demonstrates creation of a definitive perineal urethrostomy for management of severe urethral strictures.

This video demonstrates buccal mucosa graft urethroplasty for lengthy bulbar urethral strictures that are not amenable to excision and primary anastomotic urethroplasty.

This video demonstrates a posterior urethroplasty for treatment of pelvic fracture urethral injury.

Multiparametric MRI of the prostate with subsequent targeted biopsy shows promise for improving the identification of men on active surveillance for low-risk prostate cancer who require definitive treatment, according to researchers from the Vancouver Prostate Centre, Vancouver, BC.

Urologists with higher surgical volumes, especially in robotic procedures, are more likely to recommend immediate treatment than active surveillance in men with low-risk prostate cancer, according to a recent study.

Despite a recent study’s promise, downsides to the procedure remain, according to one of the study’s authors.

In the experience of Martin Miner, MD, and Joel Heidelbaugh, MD, men’s health is far more than the working relationship between urology and primary care centered around male-specific medical concerns, and includes several different and significant subspecialties.

Narrow provider networks are gaining ground among insurers and could impact patient access to urologists. While insurers tout the approach to care as a way to control costs and preserve quality, urologists and others question whether the payment model is all about cost.

Use of targeted magnetic resonance/ultrasound fusion biopsy (“targeted biopsy”) resulted in the diagnosis of significantly more high-risk prostate cancers and significantly fewer low-risk cancers compared with a standardized systematic biopsy technique, reported the authors of a new study from the National Cancer Institute.

GI complications add more than $3,000 to the cost of care for a Medicare beneficiary, researchers report.

The use of PSA is not straightforward. It’s not simple or easy. But the last time I checked, we physicians went to school for a long time so that we could explain complicated problems to our patients.

In this column, Ross E. Weber of the AACU examines where various proposals to address the specialist physician shortage currently stand.

In a series of articles, urologist Robert A. Dowling, MD, reviews aspects of the National Quality Forum's “Safe Practices for Better Healthcare” consensus recommendations that are relevant to quality and safety in urologic practice.

In this interview, Patrick H. McKenna, MD, former chairman of the AUA’s Judicial & Ethics Committee, discusses self-referral as well as the AUA expert witness program, conflicts of interest, and live surgical demonstrations.

If further work with irreversible electroporation refines its capacity for discrete tissue ablation deep within the kidney and adjacent to large blood vessels, and especially if larger tumors can be addressed, then this would be a major step forward in the minimally invasive treatment of localized renal cancer.

Percutaneous irreversible electroporation is showing promise as a novel minimally invasive approach for treating small renal tumors, according to the experience of urologists at the University of Texas Southwestern Medical Center, Dallas.

African-American men with very low-risk prostate cancer being followed on active surveillance are at significantly higher risk for disease upgrading on subsequent biopsy compared to Caucasian men, according to analyses of prospectively collected data from the Johns Hopkins Active Surveillance registry.